Ledger.Open graph →
SEC Form D · filed June 20, 2018

Metacrine, Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Robert Adelman · DURHAM, NCDirectorRichard Heyman · San Diego, CADirectorKenneth Song · San Diego, CAExec · DirectorRonald Evans · SAN DIEGO, CADirectorKristina Burow · Chicago, ILDirectorCarol Gallagher · San Diego, CADirectorPatricia Millican · San Diego, CAExecAmir Nashat · Cambridge, MADirectorRobert Adelman · South San Francisco, CADirectorKristina Burow · Ann Arbor, MIDirectorCarol Gallagher · San Diego, CADirectorRichard Heyman · San Diego, CADirectorPatricia Millican · San Diego, CAExecKenneth Song · San Jose, CAExec · DirectorRonald Evans · SAN DIEGO, CADirectorAmir Nashat · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗